Literature DB >> 20971832

Kroppenstedtia eburnea gen. nov., sp. nov., a thermoactinomycete isolated by environmental screening, and emended description of the family Thermoactinomycetaceae Matsuo et al. 2006 emend. Yassin et al. 2009.

Mathias von Jan1, Nicole Riegger2, Gabriele Pötter1, Peter Schumann1, Susanne Verbarg1, Cathrin Spröer1, Manfred Rohde3, Bettina Lauer2, David P Labeda4, Hans-Peter Klenk1.   

Abstract

A Gram-positive, spore-forming, aerobic, filamentous bacterium, strain JFMB-ATE(T), was isolated in 2008 during environmental screening of a plastic surface in grade C in a contract manufacturing organization in southern Germany. The isolate grew at temperatures of 25-50 °C and at pH 5.0-8.5, forming ivory-coloured colonies with sparse white aerial mycelia. Chemotaxonomic and molecular characteristics of the isolate matched those described for members of the family Thermoactinomycetaceae, except that the cell-wall peptidoglycan contained LL-diaminopimelic acid, while all previously described members of this family display this diagnostic diamino acid in meso-conformation. The DNA G+C content of the novel strain was 54.6 mol%, the main polar lipids were diphosphatidylglycerol, phosphatidylethanolamine and phosphatidylglycerol, and the major menaquinone was MK-7. The major fatty acids had saturated C₁₄-C₁₆ branched chains. No diagnostic sugars were detected. Based on the chemotaxonomic results and 16S rRNA gene sequence analysis, the isolate is proposed to represent a novel genus and species, Kroppenstedtia eburnea gen. nov. sp. nov. The type strain is JFMB-ATE(T) ( = DSM 45196(T)  = NRRL B-24804(T)  = CCUG 59226(T)).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971832     DOI: 10.1099/ijs.0.026179-0

Source DB:  PubMed          Journal:  Int J Syst Evol Microbiol        ISSN: 1466-5026            Impact factor:   2.747


  5 in total

1.  Isolation and identification of Kroppenstedtia eburnea isolates from multiple patient samples.

Authors:  Adam P Barker; Keith E Simmon; Sam Cohen; E Susan Slechta; Mark A Fisher; Robert Schlaberg
Journal:  J Clin Microbiol       Date:  2012-08-01       Impact factor: 5.948

2.  A systematic approach for discovering novel, clinically relevant bacteria.

Authors:  Robert Schlaberg; Keith E Simmon; Mark A Fisher
Journal:  Emerg Infect Dis       Date:  2012-03       Impact factor: 6.883

3.  Draft Genome Sequence of Kroppenstedtia sanguinis X0209T, a Clinical Isolate Recovered from Human Blood.

Authors:  Robert A Arthur; Ainsley C Nicholson; Ben W Humrighouse; John R McQuiston; Brent A Lasker
Journal:  Microbiol Resour Announc       Date:  2019-06-13

4.  Effects of aging on the quality of roasted sesame-like flavor Daqu.

Authors:  Guangsen Fan; Zhilei Fu; Chao Teng; Pengxiao Liu; Qiuhua Wu; Md Khondakar Raziur Rahman; Xiuting Li
Journal:  BMC Microbiol       Date:  2020-03-26       Impact factor: 3.605

5.  Bioactive Synthetic-Bioinformatic Natural Product Cyclic Peptides Inspired by Nonribosomal Peptide Synthetase Gene Clusters from the Human Microbiome.

Authors:  John Chu; Xavier Vila-Farres; Sean F Brady
Journal:  J Am Chem Soc       Date:  2019-09-27       Impact factor: 15.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.